Chloroquine and Hydroxychloroquine not licensed for coronavirus treatment
The MHRA has released guidance saying that Chloroquine and Hydroxychloroquine are not licensed for coronavirus treatment. Recent media reports have suggested that chloroquine can protect...
AstraZeneca is donating face masks to healthcare workers around the world
AstraZeneca is donating nine million face masks to support healthcare workers around the world as they respond to the COVID-19 (novel coronavirus) global pandemic. AstraZeneca...
Government protects high demand medicines for coronavirus patients
The Government has protected high demand medicines for coronavirus patients, with more than 80 medicines used to treat COVID-19 patients in intensive care units...
Boost to COVID-19 vaccine and therapy research
COVID-19 vaccine and therapy research has been boosted by six new projects in rapid response. The six new studies into the novel coronavirus have...
UK to map coronavirus spread with whole genome sequence alliance
The UK is to map coronavirus spread with the launch of a whole genome sequence alliance.
The Government and the UK’s Chief Scientific Adviser have...
Celltrion Group completes first step in developing antiviral treatment to fight COVID-19
Celltrion Group today announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic. As part of its emergency preparedness plan...
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
eyeforpharma Barcelona goes VIRTUAL
Spotlight: Advertorial from Pf Partners
Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
CMA launches COVID-19 taskforce to monitor market practices
The CMA is launching a COVID-19 taskforce to tackle negative impacts within its remit of the coronavirus pandemic. The outbreak of Covid-19 is an unprecedented...
LifeArc launches £10m COVID-19 clinical research fund
LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Latest articles
Primary care networks and mental health services post COVID-19
Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...
Preparing pharma for end of Brexit transition: ABPI response
The Department of Health and Social Care has published a letter setting out the Government’s plan and requests of industry and the wider supply chain...
Common chronic pain treatments ‘can do more harm than good’
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Preparing pharma for end of Brexit transition: ABPI response
The Department of Health and Social Care has published a letter setting out the Government’s plan and requests of industry and the wider supply chain...
COVID-19: Pharma on the frontline
Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Orphan Drug Designation granted to tinostamustine in EU for very rare form of leukaemia
Mundipharma has announced that the European Commission (EC) has now adopted the European Medicines Agency (EMA) Committee for Orphan Medicinal Products recommendation to grant...
Rapid change COVID-19 & UK clinical research
Dr Matthew Hallsworth, Head of External Relations at the National Institute for Health Research, looks how COVID-19 has brought about rapid change of clinical...